BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18600031)

  • 1. The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions.
    Yao Q; Pawlaczyk K; Ayala ER; Styszynski A; Breborowicz A; Heimburger O; Qian JQ; Stenvinkel P; Lindholm B; Axelsson J
    Nephron Exp Nephrol; 2008; 109(2):e71-8. PubMed ID: 18600031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
    Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
    Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma agonists diminish peritoneal functional and morphological changes induced by bioincompatible peritoneal dialysis solution.
    Yao Q; Pawlaczyk K; Ayala ER; Kuzlan M; Styszynski A; Breborowicz A; Heimburger O; Qian J; Stenvinkel P; Axelsson J; Lindholm B
    Blood Purif; 2006; 24(5-6):575-82. PubMed ID: 17124426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
    Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
    Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
    Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
    J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure.
    Loureiro J; Schilte M; Aguilera A; Albar-Vizcaíno P; Ramírez-Huesca M; Pérez-Lozano ML; González-Mateo G; Aroeira LS; Selgas R; Mendoza L; Ortiz A; Ruíz-Ortega M; van den Born J; Beelen RH; López-Cabrera M
    Nephrol Dial Transplant; 2010 Apr; 25(4):1098-108. PubMed ID: 20067910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
    Hong M; Nie Z; Chen Z; Yu X; Bao B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies.
    Hung KY; Huang JW; Chiang CK; Tsai TJ
    Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of TGF-beta1/Smads in the development of peritoneal fibrosis induced by high glucose peritoneal dialysate and LPS].
    Dou XR; Yu XQ; Li XY; Chen WF; Hao WK; Jia ZJ; Peng WX; Wang X; Yin PD; Wang WJ; Zheng ZH
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2613-8. PubMed ID: 16321321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis.
    Guo H; Leung JC; Lam MF; Chan LY; Tsang AW; Lan HY; Lai KN
    J Am Soc Nephrol; 2007 Oct; 18(10):2689-703. PubMed ID: 17855642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling.
    Shentu Y; Li Y; Xie S; Jiang H; Sun S; Lin R; Chen C; Bai Y; Zhang Y; Zheng C; Zhou Y
    Int Immunopharmacol; 2021 Apr; 93():107374. PubMed ID: 33517222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
    Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
    Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
    Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adhesion molecules in the progression of peritoneal sclerosis.
    Imai H; Nakamoto H; Fukushima R; Ishida Y; Yamanouchi Y; Suzuki H
    Adv Perit Dial; 2003; 19():180-5. PubMed ID: 14763058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the effect of high glucose on the expression of Smad in human peritoneal mesothelial cells.
    Yao Q; Qian JQ; Lin XH; Lindholm B
    Int J Artif Organs; 2004 Oct; 27(10):828-34. PubMed ID: 15560676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of new peritoneal dialysis solutions, pyridoxamine and AT1 receptor blocker, on TGF-beta1 and VEGF expression in rat peritoneal mesothelial cells.
    Mizuiri S; Ohashi Y; Hemmi H; Arita M; Yamada K; Aoki T; Miyagi M; Sakai K; Aikawa A
    Am J Nephrol; 2009; 30(3):295-302. PubMed ID: 19546527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
    Costalonga EC; de Freitas LJ; Aragone DDSP; Silva FMO; Noronha IL
    PLoS One; 2017; 12(9):e0184302. PubMed ID: 28873458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.